Literature DB >> 1556230

Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori.

S J van Zanten1, J Goldie, J Hollingsworth, C Silletti, H Richardson, R H Hunt.   

Abstract

AIMS: To study whether differences in eradication rates of antibiotics may be explained by differences in secretion of antibiotics in gastric juice.
METHODS: A single intravenous dose of either ampicillin 500 mg, erythromycin 500 mg, or metronidazole 500 mg was administered to four healthy Helicobacter pylori negative volunteers on different days. Antibiotic concentrations were measured in gastric juice before and every 10 minutes after administration of the drug for two hours and after one hour in serum.
RESULTS: No ampicillin was detected in gastric juice. Erythromycin concentrations in gastric juice showed considerable individual variation and reached maximum concentrations of 2.2-4.8 mcg/ml between 30 and 80 minutes after dosing. Metronidazole concentrations in gastric juice showed much less individual variation and maximum concentrations of 5-6 mcg/ml were reached within 30 minutes and remained high during the study period.
CONCLUSION: Metronidazole and erythromycin are secreted across the gastric mucosa, but ampicillin is not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556230      PMCID: PMC495478          DOI: 10.1136/jcp.45.3.225

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  The treatment of Campylobacter-associated gastritis.

Authors:  C A McNulty
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

5.  Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis.

Authors:  W Langenberg; E A Rauws; A Widjojokusumo; G N Tytgat; H C Zanen
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 6.  The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.

Authors:  E Bayerdörffer; R Ottenjann
Journal:  Scand J Gastroenterol Suppl       Date:  1988

7.  Optimized liquid-chromatographic determination of metronidazole and its metabolites in plasma.

Authors:  R A Gibson; L Lattanzio; H McGee
Journal:  Clin Chem       Date:  1984-05       Impact factor: 8.327

8.  Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.

Authors:  G Börsch; U Mai; K M Müller
Journal:  Scand J Gastroenterol Suppl       Date:  1988

9.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

10.  Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.

Authors:  C A McNulty; J C Dent; G A Ford; S P Wilkinson
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

View more
  10 in total

1.  Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.

Authors:  Y J Debets-Ossenkopp; F Namavar; D M MacLaren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

2.  In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents.

Authors:  A F Goddard; R C Spiller
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 3.  Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors:  Javier P Gisbert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

5.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

6.  Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.

Authors:  F Mégraud; A Occhialini; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.

Authors:  M Hirai; T Azuma; S Ito; T Kato; Y Kohli
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

Review 8.  Indications for treatment of Helicobacter pylori infection: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

9.  Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori.

Authors:  S J Veldhuyzen van Zanten; P T Pollak; H Kapoor; P K Yeung
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

Review 10.  Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review.

Authors:  Ilaria Maria Saracino; Matteo Pavoni; Angelo Zullo; Giulia Fiorini; Tiziana Lazzarotto; Claudio Borghi; Dino Vaira
Journal:  Antibiotics (Basel)       Date:  2021-04-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.